project id: TCGA-BLCA; case submitter id: TCGA-4Z-AA7R; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.77; rna integrity number: 9.6; age at index: 73; days to birth: -26781; days to death: 522; ethnicity: not reported; gender: male; race: black or african american; vital status: Dead; year of birth: 1937; age at diagnosis: 26781; ajcc clinical t: T2a; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IV; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 493.0; icd 10 code: C67.0; last known disease status: not reported; morphology: 8130/3; primary diagnosis: Papillary transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Trigone of bladder; synchronous malignancy: No; tissue or organ of origin: Trigone of bladder; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1189; days to sample procurement: 0; initial weight: 350.0; portion submitter id: TCGA-4Z-AA7R-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 75.0;